Predictors of genetic testing decisions: A systematic review and critique of the literature

Journal of Genetic Counseling

Volumn 23, Issue 3, 2014, Pages 263-288

  Sweeny, Kate ^a   Ghane, Arezou ^a   Legg, Angela M ^b   Huynh, Ho Phi ^a   Andrews, Sara E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PACE UNIVERSITY   (United States)

Author keywords

BRCA1 2; Decision making; Direct to consumer; Genetic testing; Intentions; Systematic review

Indexed keywords

DECISION MAKING; GENETIC SCREENING; HUMAN; RISK ASSESSMENT;

DECISION MAKING; GENETIC TESTING; HUMANS; RISK ASSESSMENT;

EID: 84901941440     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-014-9712-9     Document Type: Review

References (143)

1. Ajzen, I. (2002). Perceived behavioral control, self-efficacy, locus of control, and the theory of planned behavior. Journal of Applied Social Psychology, 32, 665-683.
2. Ajzen, I.; & Fishbein, M. (1977). Attitude-behavior relations: a theoretical analysis and review of empirical research. Psychological Bulletin, 84, 888-918.
3. Aktan-Collan, K.; Mecklin, J.-P.; Jarvinen, H.; Nyström-Lahti, M.; Peltomäki, P.; Söderling, I.; et al. (2000). Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. International Journal of Cancer (Predictive Oncology), 89, 44-50. (Pubitemid 30078749)
4. Andrews, L.; Meiser, B.; Apicella, C.; & Tucker, K. (2004). Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study. Genetic Testing, 8, 241-247.
5. Andrykowski, M. A.; Munn, R. K.; & Studts, J. L. (1996). Interest in learning of personal genetic risk for cancer: a general population survey. Preventive Medicine, 25, 527-536. (Pubitemid 26315224)
6. Bates, M. D.; Quinn Griffin, M. T.; Killion, C. M.; & Fitzpatrick, J. J. (2011). African-American males' knowledge and attitudes toward genetic testing and willingness to participate in genetic testing: a pilot study. Journal of National Black Nurses Association, 22, 1-7.
7. Becker, M. H. (Ed.) (1974). The health belief model and personal health behavior. Health Education Monographs, 2, 324-473.
8. Bernhardt, B. A.; Geller, G.; Stauss, M.; Helzlsouer, K. J.; Stefanek, M.; Wilcox, P. M.; et al. (1997). Toward a model informed consent process for BRCA1 testing: a qualitative assessment of women's attitudes. Journal of Genetic Counseling, 6, 207-222. (Pubitemid 127716876)
9. Biesecker, B. B.; Ishibe, N.; Hadley, D. W.; Giambarresi, T. R.; Kase, R. G.; Lerman, C.; et al. (2000). Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. American Journal of Medical Genetics, 93, 257-263. (Pubitemid 30497442)
10. Binedell, J.; Soldan, J. R.; & Harper, P. S. (1998). Predictive testing for Huntington's disease: I. Predictors of uptake in South Wales. Clinical Genetics, 54, 477-488. (Pubitemid 29002411)
11. Bloch, M.; Fahy, M.; Fox, S.; & Hayden, M. R. (1989). Predictive testing for Huntington's disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. American Journal of Medical Genetics, 32, 217-224. (Pubitemid 19079376)
12. Bosompra, K.; Flynn, B. S.; Ashikaga, T.; Rairikar, C. J.; Worden, J. K.; & Solomon, L. J. (2000). Likelihood of undergoing genetic testing for cancer risk: a population-based study. Preventive Medicine, 30, 155-166. (Pubitemid 30094247)
13. Bosompra, K.; Ashikaga, T.; Flynn, B. S.; Worden, J. K.; & Solomon, L. J. (2001). Psychosocial factors associated with the public's willingness to pay for genetic testing for cancer risk: a structural equations model. Health Education Research, 16, 157-172. (Pubitemid 32401912)
14. Botoseneanu, A.; Alexander, J. A.; & Banaszak-Holl, J. (2011). To test or not to test? The role of attitudes, knowledge, and religious involvment among U.S. adults on intent-to-obtain adult genetic testing. Health Education & Behavior, 38, 617-628.
15. Bottorff, S. L.; Ratner, P. A.; & Balneaves, L. G. (2002). Women's Interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge. Cancer Epidemiology, Biomarkers & Prevention, 11, 89-95. (Pubitemid 34118317)
16. Braithwaite, D.; Sutton, S.; & Steggles, N. (2002). Intention to participate in predictive genetic testing for hereditary cancer: the role of attitude toward uncertainty. Psychology & Health, 17, 761-772.
17. Bratt, O.; Damber, J.-E.; Emanuelsson, M.; Kristoffersson, U.; Lundgren, R.; Olsson, H.; et al. (2000). Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. European Journal of Cancer, 36, 235-241. (Pubitemid 30102201)
18. Bunn, J. Y.; Bosompra, K.; Ashikaga, T.; Flynn, B. S.; & Worden, J. K. (2002). Factors influencing intention to obtain a genetic test for colon cancer risk: a population-based study. Preventive Medicine, 34, 567-577. (Pubitemid 34971657)
19. Cameron, L. D.; & Diefenbach, M. A. (2001). Responses to information about psychosocial consequences of genetic testing for breast cancer susceptibility: influences of cancer worry and risk perception. Journal of Health Psychology, 6, 47-59. (Pubitemid 32125042)
20. Cameron, L. D.; & Reeve, J. (2006). Risk perceptions, worry, and attitudes about genetic testing for breast cancer susceptibility. Psychology & Health, 21, 211-230. (Pubitemid 43663667)
21. Cameron, L. D.; Sherman, K. A.; Marteau, T. M.; & Brown, P. M. (2009). Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychology, 28, 307-316.
22. Cappelli, M.; Surh, L.; Humphreys, L.; Verma, S.; Logan, D.; Hunter, A.; et al. (1999). Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clinical Genetics, 55, 419-430. (Pubitemid 29335638)
23. Cappelli, M.; Surh, L.; Humphreys, L.; Verma, S.; Logan, D.; & Allanson, J. (2001). Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing. Quality of Life Research, 10, 595-607. (Pubitemid 34056330)
24. Cappelli, M.; Hunter, A. G. W.; Stern, H.; Humphreys, L.; Van Houten, L.; O'Rourke, K.; et al. (2002). Participation rates of Ashkenazi Jews in a colon cancer community-based screening/prevention study. Clinical Genetics, 61, 104-114. (Pubitemid 36372615)
25. Chaliki, H.; Loader, S.; Levenkron, J. C.; Logan-Young, W.; Hall, W. J.; & Rowley, P. T. (1995). Women's receptivity to testing for a genetic susceptibility to breast cancer. American Journal of Public Health, 85, 1133-1135.
26. Cherkas, L. F.; Harris, J. M.; Levinson, E.; Spector, T. D.; & Prainsack, B. (2010). A survey of UK public interest in internet-based personal genome testing. PLoS One, 5, e13473.
27. Codori, A.-M.; Hanson, R.; & Brandt, J. (1994). Self-selection in predictive testing for Huntington's disease. American Journal of Medical Genetics, 54, 167-173. (Pubitemid 24292177)
28. Codori, A. M.; Petersen, G. M.; Miglioretti, D. L.; Larkin, E. K.; Bushey, M. T.; Young, C.; et al. (1999). Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiology, Biomarkers & Prevention, 8, 345-351. (Pubitemid 29193889)
29. Cragun, D.; Malo, T. L.; Pal, T.; Shibata, D.; & Vadaparampil, S. T. (2012). Colorectal cancer survivors' interest in genetic testing for hereditary cancer: implications for universal tumor screening. Genetic Testing & Molecular Biomarkers, 16, 493-499.
30. Craufurd, D.; Kerzin-Storrar, L.; Dodge, A.; & Harris, R. (1989). Uptake of presymptomatic predictive testing for Huntington's disease. The Lancet, 334, 603-605. (Pubitemid 19216216)
31. Croyle, R. T.; & Lerman, C. (1993). Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Preventive Medicine, 22, 284-292. (Pubitemid 23150670)
32. Croyle, R. T.; Dutson, D. S.; Tran, V. T.; & Sun, Y.-C. (1995). Need for certainty and interest in genetic testing. Women's Health: Research on Gender, Behavior, & Policy, 1, 329-339.
33. Culler, D. D.; Silberg, J.; Vanner-Nicely, L.; Ware, J. L.; Jackson-Cook, C.; & Bodurtha, J. (2002). Factors influencing men's interest in gene testing for prostate cancer susceptibility. Journal of Genetic Counseling, 11, 383-398. (Pubitemid 41450828)
34. Culver, J.; Burke, W.; Yasui, Y.; Durfy, S.; & Press, N. (2001). Participation in breast cancer genetic counseling: the influence of education level, ethnic background, and risk perception. Journal of Genetic Counseling, 10, 215-231. (Pubitemid 33818208)
35. Cutler, S. J.; & Hodgson, L. G. (2003). To test or not to test: Interest in genetic testing for Alzheimer's disease among middle-aged adults. American Journal of Alzheimer's Disease & Other Dementias, 18, 9-20. (Pubitemid 36222531)
36. Cyr, A.; Dunnagan, T. A.; & Haynes, G. (2010). Efficacy of the health belief model for predicting intention to pursue genetic testing for colorectal cancer. Journal of Genetic Counseling, 19, 174-186.
37. DiLorenzo, T. A.; Schnur, J.; Montgomery, G. H.; Erblich, J.; Winkel, G.; & Bovbjerg, D. H. (2006). A model of disease-specific worry in heritable disease: the influence of family history, perceived risk and worry about other illnesses. Journal of Behavioral Medicine, 29, 37-49. (Pubitemid 43345144)
38. Dugas, M. J.; Gagnon, F.; Ladouceur, R.; & Freeston, M. H. (1998). Generalized anxiety disorder: a preliminary test of a conceptual model. Behaviour Research and Therapy, 36, 215-226. (Pubitemid 28234081)
39. Durfy, S. J.; Bowen, D. J.; McTiernan, A.; Sporleder, J.; & Burke, W. (1999). Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in Western Washington. Cancer Epidemiology, Biomarkers & Prevention, 8, 369-375. (Pubitemid 29193892)
40. Ellison, C. W.; & Smith, J. (1991). Toward an integrative measure of health and well being. Journal of Psychological Theology, 19, 35-48.
41. Etchegary, H. (2004). Psychological aspects of predictive genetic-test decisions: what do we know so far? Analyses of Social Issues & Public Policy, 4, 13-31.
42. Etchegary, H.; Capelli, M.; Potter, B.; Vloet, M.; Graham, I.; Walker, M.; et al. (2010). Attitude and knowledge about genetics and genetic testing. Public Health & Genomics, 13, 80-88.
43. Evers-Kiebooms, G.; & Decruyenaere, M. (1998). Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals. Patient Education & Counseling, 35, 15-26. (Pubitemid 29037810)
44. Evers-Kiebooms, G.; Swerts, A.; Cassiman, J. J.; & Van Den Berghe, H. (1989). The motivation of at-risk individuals and their partners in deciding for or against predictive testing for Huntington's disease. Clinical Genetics, 35, 29-40. (Pubitemid 19029789)
45. Evers-Kiebooms, G.; Welkenhuysen, M.; Claes, E.; Decruyenaere, M.; & Denayer, L. (2000). The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: Implications for multidisciplinary counselling and for genetic education. Social Science & Medicine, 51, 831-841. (Pubitemid 30326784)
46. Fisher, A.; Bonner, C.; Biankin, A.; & Juraskova, I. (2012). Factors influencing intention to undergo whole genome screening in future healthcare: a single-blind parallel-group randomised trial. Preventive Medicine, 55, 514-520.
47. Foster, C.; Evans, D. G. R.; Eeles, R.; Eccles, D.; Ashley, S.; Brooks, L.; et al. (2004). Non-uptake of predicitve testing for BRCA1/2 among relatives of known carriers: attributes, cancer, worry, and barriers to testing in a multicenter clinical cohort. Genetic Testing, 8, 23-29. (Pubitemid 38529666)
48. Frost, S.; Myers, L. B.; & Newman, S. P. (2001). Genetic screening for Alzheimer's disease: what factors predict intentions to take a test? Behavioral Medicine, 27(3), 101-109. (Pubitemid 34591765)
49. Fulda, K. G.; & Lykens, K. (2006). Ethical issues in predictive genetic testing: a public health perspectives. Journal of Medical Ethics, 32, 143-147. (Pubitemid 43338117)
50. Glanz, K.; Grove, J.; Lerman, C.; Gotay, C.; & Le Marchand, L. (1999). Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiology, Biomarkers & Prevention, 8, 329-336. (Pubitemid 29193887)
51. Godard, B.; Pratte, A.; Dumont, M.; Simard-Lebrun, A.; & Simard, J. (2007). Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling. Genetic Testing, 11, 45-54. (Pubitemid 46557357)
52. Gooding, H. C.; Organista, K.; Burack, J.; & Biesecker, B. B. (2006). Genetic susceptibility testing from a stress and coping perspective. Social Science & Medicine, 62, 1880-1890.
53. Graham, I. D.; Logan, D. M.; Hughes-Benzie, R.; Evans, W. K.; Perras, H.; McAuley, L. M.; et al. (1998). How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey. Cancer Prevention & Control, 2, 167-172. (Pubitemid 28439471)
54. Gray, S. W.; Hornik, R. C.; Schwartz, J. S.; & Armstrong, K. (2012). The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations. Clinical Genetics, 81, 29-37.
55. Gwyn, K.; Vernon, S. W.; & Conoley, P. M. (2003). Intention to pursue genetic testing for breast cancer among women due for screening mammography. Cancer Epidemiology, Biomarkers & Prevention, 12, 96-102. (Pubitemid 36193998)
56. Hadley, D. W.; Jenkins, J.; Dimond, E.; Nakahara, K.; Grogan, L.; Liewehr, D. J.; et al. (2003). Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Archives of Internal Medicine, 163, 573-582. (Pubitemid 36314345)
57. Hailey, B. J.; Carter, C. L.; & Burnett, D. R. (2000). Breast cancer attitudes, knowledge, and screening behavior in women with and without a family history of breast cancer. Health Care for Women International, 21, 701-715.
58. Hall, J.; Gray, S.; A'Hern, R.; Shanley, S.; Watson, M.; Kash, K.; et al. (2009). Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines. Familial Cancer, 8, 5-13.
59. Harel, A.; Abuelo, D.; & Kazura, A. (2003). Adolescents and genetic testing: what do they think about it? Journal of Adolescent Health, 33, 489-494. (Pubitemid 37463560)
60. Helmes, A. W. (2002). Application of the protective motivation theory to genetic testing for breast cancer risk. Preventive Medicine, 35, 453-462. (Pubitemid 35352215)
61. Helmes, A. W.; Culver, J. O.; & Bowen, D. J. (2006). Results of a randomized study of telephone versus in-person breast cancer risk counseling. Patient Education & Counseling, 64, 96-103. (Pubitemid 44772946)
62. Hiraki, S.; Chen, C. A.; Roberts, J. S.; Cupples, L. A.; & Green, R. C. (2009). Perceptions of familial risk in those seeking genetic risk assessment for Alzheimer's disease. Journal of Genetic Counseling, 18, 130-136.
63. Holloway, S. M.; Bernhard, B.; Campbell, H.; & Lam, W. W. K. (2008). Uptake of testing for BRCA1/2 mutations in South East Scotland. European Journal of Human Genetics, 16, 906-912.
64. Hughes, C.; Gomez-Caminero, A.; Benkendorf, J.; Kerner, J.; Isaacs, C.; Barter, J.; et al. (1997). Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Education & Counseling, 32, 51-62. (Pubitemid 27395979)
65. Jacobsen, P. B.; Valdimarsdottir, H. B.; Brown, K. L.; & Offitt, K. (1997). Decision-making about genetic testing among women at familiar risk for breast cancer. Psychosomatic Medicine, 59, 459-466. (Pubitemid 27422242)
66. Jacopini, G. A.; D'Amico, R.; & Vivona, G. (1992). Attitudes of persons at risk and their partners toward predictive testing. Birth Defects, 28, 113-117.
67. Janz, N.; & Becker, M. (1984). The health belief model: a decade later. Health Education Quarterly, 11, 1-47.
68. Julian-Reynier, C.; Sobol, H.; Sevilla, C.; Nogues, C.; & Bourret, P. (2000). Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. Psycho-Oncology, 9, 504-510. (Pubitemid 32010923)
69. Kasparian, N. A.; Meiser, B.; Butow, P. N.; Simpson, J. P.; & Mann, G. J. (2009). Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families. Genetic Medicine, 11, 265-278.
70. Kelly, K.; Leventhal, H.; Andrykowski, M.; Toppmeyer, D.; Much, J.; Dermody, J.; et al. (2004). The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations. Journal of Genetic Counseling, 13, 237-257. (Pubitemid 39012929)
71. Keogh, L. A.; Southey, M. C.; Maskiell, J.; Young, M. A.; Gaff, C. L.; Kirk, J.; et al. (2004). Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study. Cancer Epidemiology, Biomarkers & Prevention, 13, 2258-2263. (Pubitemid 40054326)
72. Kinney, A. Y.; Choi, Y.-A.; DeVellis, B.; Kobetz, E.; Millikan, R. C.; & Sandler, R. S. (2000). Interest in genetic testing among first-degree relatives of colorectal cancer patients. American Journal of Preventive Medicine, 18, 249-252. (Pubitemid 30155674)
73. Kinney, A. Y.; Croyle, R. T.; Dudley, W. N.; Bailey, C. A.; Pelias, M. K.; & Neuhausen, S. L. (2001). Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-american kindred with a BRCA1 mutation. Preventive Medicine, 33, 543-551. (Pubitemid 34101877)
74. Klitzman, R.; Thorne, D.; Williamson, J.; & Marder, K. (2007). The roles of family members, health care workers, and others in decision-making processes about genetic testing among individuals at risk for Huntington disease. Genetic Medicine, 9, 358-371. (Pubitemid 46956478)
75. Laegsgaard, M. M.; Kristensen, A. S.; & Mors, O. (2009). Potential consumers' attitudes toward psychiatric genetic research and testing and factors influencing their intentions to test. Genetic Testing & Molecular Biomarkers, 13, 57-65.
76. Lee, S. C.; Bernhardt, B. A.; & Helzlsouer, K. J. (2002). Utilization of BRCA1/2 genetic testing in the clinical setting. Cancer, 94, 1876-1885. (Pubitemid 34241127)
77. Lerman, C.; Narod, S.; Schulman, K.; Hughes, C.; Gomez-Caminero, A.; Bonney, G.; et al. (1996). BRCA1 Testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. JAMA, 275, 1885-1892. (Pubitemid 26196448)
78. Lerman, C.; Schwartz, M. D.; Lin, T. H.; Hughes, C.; Narod, S.; & Lynch, H. T. (1997). The influence of psychological distress on use of genetic testing for cancer risk. Journal of Consulting and Clinical Psychology, 65, 414-420. (Pubitemid 27246782)
79. Lerman, C.; Hughes, C.; Trock, B. J.; Myers, R. E.; Main, D.; Bonney, A.; et al. (1999). Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA, 281, 1618-1622. (Pubitemid 29211771)
80. Lerman, C.; Croyle, R. T.; Tercyak, K. P.; & Hamann, H. (2002). Genetic testing: psychological aspects and implications. Journal of Consulting and Clinical Psychology, 70, 784-797. (Pubitemid 34640743)
81. Lipkus, I. M.; Iden, D.; Terrenoire, J.; & Feaganes, J. R. (1999). Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. Cancer Epidemiology, Biomarkers & Prevention, 8, 533-539. (Pubitemid 29270338)
82. Lynch, H. T.; Snyder, C. L.; Lynch, J. F.; Ghate, S.; Narod, S. A.; & Gong, G. (2009). Family information service participation increases the rates of mutation testing among members of families with BRCA1/2 mutations. The Breast Journal, 15, 20-24.
83. Mastromauro, C.; Myers, R. H.; & Berkman, B. (1987). Attitudes toward presymptomatic testing in Huntington disease. American Journal of Medical Genetics, 26, 271-282.
84. McGuire, A. L.; Diaz, C. M.; Wang, T.; & Hilsenbeck, S. G. (2009). Social networkers' attitudes toward direct-to-consumer personal genome testing. The American Journal of Bioethics, 9, 3-10.
85. Meijers-Heijboer, E. J.; Verhoog, L. C.; Brekelmans, C. T. M.; Seynaeve, C.; Tilanus-Linthorst, M. M. A.; Wagner, A.; et al. (2000). Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. The Lancet, 355, 2015-2020. (Pubitemid 30339238)
86. Meiser, B. (2005). Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-Oncology, 14, 1060-1074. (Pubitemid 43019695)
87. Meiser, B.; & Dunn, S. (2000). Psychological impact of genetic testing for Huntington's disease: an update of the literature. Journal of Neurology, Neurosurgery & Psychiatry, 69, 574-578.
88. Meiser, B.; Butow, P.; Barratt, A.; Suthers, G.; Smith, M.; Colley, A.; et al. (2000). Attitudes to genetic testing for breast cancer susceptibility in women at increased risk of developing hereditary breast cancer. Journal of Medical Genetics, 37, 472-476. (Pubitemid 30386746)
89. Meissen, G. J.; & Berchek, R. L. (1987). Intentions to use predictive testing by those at risk for Huntington's disease: implications for prevention. American Journal of Community Psychology, 16, 261-277.
90. Metcalfe, K. A.; Fan, I.; McLaughlin, J.; Risch, H. A.; Rosen, B.; Murphy, J.; et al. (2009). Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study. Gynecologic Oncology, 112, 68-72.
91. Miller, S. M. (1987). Monitoring and blunting: validation of a questionnaire to assess styles of information seeking under threat. Journal of Personality and Social Psychology, 52, 345-353.
92. Myers, R. E.; Hyslop, T.; Jennings-Dozier, K.; Wolf, T. A.; Burgh, D. Y.; Diehl, J. A.; et al. (2000). Intention to be tested for prostate cancer risk among African-American men. Cancer Epidemiology, Biomarkers & Prevention, 9, 1323-1328. (Pubitemid 32044800)
93. National Human Genome Research Institute. (2011, October 13). An overview of the Human Genome Project. Retrieved from http://www.genome.gov/12011238. Accessed 25 March 2013
94. National Institutes of Health (2013, November 4). Genetic testing: How it is used for healthcare. Retrieved from http://report.nih.gov/NIHfactsheets/ ViewFactSheet.aspx?csid=43. Accessed 25 March 2013
95. Nisbett, R. E.; & Wilson, T. D. (1977). Telling more than we can know: verbal reports on mental processes. Psychological Review, 84, 231-259.
96. Nordin, K.; Björk, J.; & Berglund, G. (2004). Factors influencing intention to obtain a genetic test for a hereditary disease in an affected group and in the general public. Preventive Medicine, 39, 1107-1114. (Pubitemid 39468624)
97. Olaya, W.; Esquivel, P.; Wong, J. H.; Morgan, J. W.; Freeberg, A.; Roy-Chowdhury, S.; et al. (2009). Disparities in BRCA testing: when insurance coverage is not a barrier. American Journal of Surgery, 198, 562.
98. Oster, E.; Dorsey, E. R.; Bausch, J.; Shinaman, A.; Kayson, E.; Oakes, D.; et al. (2008). Fear of health insurance loss among individuals at risk for Huntington's disease. American Journal of Medical Genetics Part A, 146A, 2070-2077.
99. Paglierani, L. M.; Kalkwarf, H. J.; Rosenthal, S. L.; Huether, C. A.; & Wenstrup, R. J. (2003). The impact of test outcome certainty on interest in genetic testing among college women. Journal of Genetic Counseling, 12, 131-150. (Pubitemid 39012937)
100. Petersen, G. M.; Larkin, E.; Codori, A.; Wang, C.; Booker, S. V.; Bacon, J.; Giardiello, F. M.; & Boyd, P. A. (1999). Attitudes toward colon cancer gene testing: Survey of relatives of colon cancer patients. Cancer Epidemiology, Biomarkers & Prevention, 8, 337-344. (Pubitemid 29193888)
101. Rahman, B.; Meiser, B.; Sachdev, P.; Barlow-Stewart, K.; Otlowski, M.; Zilliacus, E.; et al. (2012). To know or not to know: an update of the literature on the psychological and behavioral impact of genetic testing for Alzheimer disease risk. Genetic Testing & Molecular Biomarkers, 16, 1-8.
102. Ramirez, A. G.; Aparicio-Ting, F. E.; Miguel, S.; de Majors, S.; & Miller, A. R. (2006). Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors. Ethnicity & Disease, 16, 398-403. (Pubitemid 46952638)
103. Reitz, F.; Barth, J.; & Bengel, J. (2004). Predictive value of breast cancer cognitions and attitudes toward genetic testing on women's interest in genetic testing for breast cancer risk. Psycho-Social Medicine, 1, 1-11.
104. Roberts, J. S. (2000). Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives. The Gerontologist, 40, 43-52. (Pubitemid 30170189)
105. Roberts, J. S.; Barber, M.; Brown, T. M.; Cupples, L. A.; Farrer, L. A.; LaRusse, S. A.; et al. (2004). Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genetic Medicine, 6, 197-203. (Pubitemid 39005859)
106. Rogers, R. W. (1983). Cognitive and psychological processes in fear appeals and attitude change: A revised theory of protection motivation. In J. T. Cacioppo & R. E. Petty (Eds.), Social psychophysiology (pp. 153-176). New York: Guilford Press.
107. Romero-Hidalgo, S.; Urraca, N.; Parra, D.; Villa, A. R.; Lisker, R.; & Carnevale, A. (2009). Attitudes and anticipated reactions to genetic testing for cancer among patients in Mexico City. Genetic Testing & Molecular Biomarkers, 13, 477-483.
108. Ruddy, K. J.; Gelber, S.; Shin, J.; Garber, J. E.; Rosenberg, R.; Przypysny, M.; et al. (2010). Genetic testing in young women with breast cancer: results from a Web-based survey. Annals of Oncology, 21, 741-747.
109. Salkovskis, P. M.; Dennis, R.; & Wroe, A. L. (1999). An experimental study of influences on the perceived likelihood of seeking genetic testing: "Nondirectiveness" may be misleading. Journal of Psychosomatic Research, 47, 439-447. (Pubitemid 30006331)
110. Salkovskis, P. M.; Rimes, K. A.; Bolton, J.; & Wroe, A. L. (2010). An experimental investigation of factors involved in the decision to undertake genetic testing for schizophrenia. Journal of Mental Health, 19, 202-210.
111. Sanderson, S. C.; Humphries, S. E.; Hubbart, C.; Hughes, E.; Jarvis, M. J.; & Wardle, J. (2008). Psychological and behavioural impact of genetic testing smokers for lung cancer risk: a phase II exploratory trial. Journal of Health Psychology, 13, 481-494. (Pubitemid 351537907)
112. Sanderson, S. C.; O'Neill, S. C.; Bastian, L. A.; Bepler, G.; & McBride, C. M. (2010). What can interest tell us about uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung cancer. Public Health Genomics, 13, 116-124.
113. Scheier, M. F.; & Carver, C. S. (1985). Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychology, 4, 219-247.
114. Schwartz, M. D.; Hughes, C.; Roth, J.; Main, D.; Peshkin, B. N.; Isaacs, C.; et al. (2000). Spiritual faith and genetic testing decisions among high-risk breast probands. Cancer Epidemiology, Biomarkers & Prevention, 9, 381-385. (Pubitemid 30265781)
115. Segal, M. E.; Polansky, M.; & Sankar, P. (2007). Predictors of uptake of obesity genetic testing among affected adults. Human Genetics, 120, 641-652. (Pubitemid 44942848)
116. Shiloh, S.; Petel, Y.; Papa, M.; & Goldman, B. (1998). Motivations, perceptions and interpersonal differences associated with interest in genetic testing for breast cancer susceptibility among women at high and average risk. Psychology & Health, 13, 1071-1086. (Pubitemid 128546504)
117. Shiloh, S.; Ben-Sinai, R.; & Keinan, G. (1999). Controllability, predictability, and information-seeking style on interest in predictive genetic testing. Personality and Social Psychology Bulletin, 25, 1187-1195.
118. Smith, K. R.; & Croyle, R. T. (1995). Attitudes toward genetic testing for colon cancer risk. American Journal of Public Health, 85, 1435-1438.
119. Smith, R. J.; & Hone, S. (2003). Genetic screening for deafness. Pediatric Clinics of North America, 50, 315-329. (Pubitemid 36666559)
120. Smith, A. W.; Dougall, A. L.; Posluszny, D. M.; Somers, T. J.; Rubinstein, W. S.; & Baum, A. (2008). Psychological distress and quality of life associated with genetic testing for breast cancer risk. Psycho-Oncology, 17, 767-773.
121. Struewing, J. P.; Lerman, C.; Kase, R. G.; Giambarresi, T. R.; & Tucker, M. A. (1995). Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiology, Biomarkers & Prevention, 4, 169-173.
122. Susswein, L. R.; Skrzynia, C.; Lange, L. A.; Booker, J. K.; Graham, M. L.; III, & Evans, J. P. (2008). Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer. Journal of Clinical Oncology, 26, 32-36.
123. Sweeny, K.; & Legg, A. M. (2011). Predictors of interest in direct-to-consumer genetic testing. Psychology & Health, 26, 1259-1272.
124. Tambor, E. S.; Rimer, B. K.; & Strigo, T. S. (1997). Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. American Journal of Medical Genetics, 68, 43-49. (Pubitemid 27023839)
125. Tibben, A.; Frets, P. G.; van de Kamp, J. J.; Niermeijer, M. F.; Vegter van der Vlis, M.; Roos, R. A.; et al. (1993). Presymptomatic DNA testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program. American Journal of Medical Genetics, 48, 10-16. (Pubitemid 23119951)
126. Trippitelli, C. L.; Jamison, K. R.; Folstein, M. F.; Bartko, J. J.; & DePaulo, J. R. (1998). Pilot study on patients' and spouses' attitudes toward potential genetic testing for bipolar disorder. American Journal of Psychiatry, 155, 899-904. (Pubitemid 28307600)
127. Ulrich, C. M.; Kristal, A. R.; White, E.; Hunt, J. R.; Durfy, S. J.; & Potter, J. D. (1998). Genetic testing for cancer risk: a population survey on attitudes and intention. Community Genetics, 1, 213-222.
128. Van der Steenstraten, I. M.; Tibben, A.; Roos, R. A.; Van de Kamp, J. J.; & Niermeijer, M. F. (1994). Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. American Journal of Human Genetics, 55(4), 618.
129. Vernon, S. W.; Gritz, E. R.; Peterson, S. K.; Perz, C. A.; Marani, S.; Amos, C. I.; et al. (1999). Intention to learn results of genetic testing for hereditary colon cancer. Cancer Epidemiology, Biomarkers & Prevention, 8, 353-360. (Pubitemid 29193890)
130. Wade, C. H.; Shiloh, S.; Woolford, S. W.; Roberts, J. S.; Alford, S. H.; Marteau, T. M.; et al. (2012). Modeling decisions to undergo genetic testing for susceptibility to common health conditions: an ancillary study of the Multiplex Initiative. Psychology & Health, 27, 430-444.
131. Wallston, K. A.; Malcarne, V. L.; Flores, L.; Hansdottir, I.; Smith, C. A.; Stein, M. J.; et al. (1999). Does God determine your health? The God locus of health control scale. Cognitive Therapy and Research, 23, 131-142. (Pubitemid 29284405)
132. Warner, B. J.; Curnow, L. J.; Polglase, A. L.; & Debinski, H. S. (2005). Factors influencing uptake of genetic testing for colorectal cancer risk in an Australian Jewish population. Journal of Genetic Counseling, 14, 387-394. (Pubitemid 41407045)
133. Webster, D. M.; & Kruglanski, A. W. (1994). Individual differences in need for cognitive closure. Journal of Personality and Social Psychology, 67, 1049-1062.
134. Welkenhuysen, M.; Evers-Kiebooms, G.; & Van den Berghe, H. (1997). Attitudes toward predictive testing for Alzheimer's disease in a student population. Psychiatric Genetics, 7, 121-126. (Pubitemid 27450087)
135. Welkenhuysen, M.; Evers-Kiebooms, G.; Decruyenaere, M.; Claes, E.; & Denayer, L. (2001). A community based study on intentions regarding predictive testing for hereditary breast cancer. Journal of Medical Genetics, 38, 540-547. (Pubitemid 32751585)
136. Westmaas, J. L.; & Woicik, P. B. (2005). Dispositional motivations and genetic risk feedback. Addictive Behaviors, 30, 1524-1534. (Pubitemid 41191296)
137. Wilde, A.; Meiser, B.; Mitchell, P. B.; Hadzi-Pavlovic, D.; & Schofield, P. R. (2010). Community interest in predictive genetic testing for susceptibility to major depressive disorder in a large national sample. Psychological Medicine, 41, 1605-1613.
138. Wilson, S.; Ryan, A. V.; Greenfield, S. M.; Clifford, S. C.; Holder, R. L.; Pattison, H. M.; et al. (2008). Self-testing for cancer: a community survey. BMC Cancer, 8, 102. (Pubitemid 351597448)
139. Withrow, K. A.; Burton, S.; Arnos, K. S.; Kalfoglou, A.; & Pandya, A. (2008). Consumer motivations for pursuing genetic testing and their preferences for the provision of genetic services for hearing loss. Journal of Genetic Counseling, 17, 252-260.
140. Wolff, K.; Nordin, K.; Brun, W.; Berglund, G.; & Kvale, G. (2011). Affective and cognitive attitudes, uncertainty avoidance and intention to obtain genetic testing: an extension of the theory of planned behaviour. Psychology & Health, 26, 1143-1155.
141. Wroe, A. L.; & Salkovskis, P. M. (1999). Factors influencing anticipated decisions about genetic testing: experimental studies. British Journal of Health Psychology, 4, 19-40. (Pubitemid 29082171)
142. Wroe, A. L.; & Salkovskis, P. M. (2000). The effects of non-directive questioning on an anticipated decision whether to undergo predictive testing for heart disease: an experimental study. Behavioral Research & Therapy, 38, 389-403. (Pubitemid 30089700)
143. Yaniv, I.; Benador, D.; & Sagi, M. (2004). On not wanting to know and not wanting to inform others: choices regarding predictive genetic testing. Risk Decision & Policy, 9, 317-336.